arrow
G

Guillaume Joe Pegna

Oregon Health and Science University
H指数:7
被引数:259

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer

卡斯珀: calaspargase pegol-mnkl和cobimetinib联合治疗胰腺癌的I期试验

2024-10-080
PRE
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers

托法替尼预防表达间皮素的晚期癌症患者针对LMB-100免疫毒素的抗药物抗体形成

2024-04-190
OAAI
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma
2022-01-058
OAAI
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
2019-01-0416
OAAI